Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,570,603
-
Share change
-
-1,453,020
-
Total reported value
-
$18,840,968
-
Put/Call ratio
-
85%
-
Price per share
-
$1.21
-
Number of holders
-
46
-
Value change
-
-$2,204,239
-
Number of buys
-
12
-
Number of sells
-
19
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q3 2015
As of 30 Sep 2015 AVEO PHARMACEUTICALS INC - COM (AVEO) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,570,603 shares of stock of the company.
Largest 10 holders included Sarissa Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., Cormorant Asset Management, LLC, Gruss Capital Management LP, Deer VI & Co. LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Greylock XI GP Limited Partnership, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 46 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.